Skip to main content
SteadySharesSteadySharesSteadyStShares
The market
MarketsDiscover
Follow the money
Super InvestorsPolitician TradesCrypto Desk
Yours
My WealthNews
Settings Sign in
Closed
SteadySharesMarketsDiscoverSuper InvestorsMy WealthPoliticiansCryptoNews
DiscoverNORD
IndustrialsOQBUSD

Nordicus Partners Corporation

$00123456789.0012345678900123456789+14.0%
52w low $1.48$5.95 52w high
Market data · last updated 1d ago
Market data
Market cap
$42.50M
52w range
$1.48 - $5.95
Sector
Industrials
Data quality
75/100
Valuation
fair value estimate
$3.44
Margin of safety
-14.0%
Quality & efficiency
Moat score
10/100
Return on equity
-6.5%
Run the 10-point checklist before you buy How these numbers are made

About Nordicus Partners Corporation

Nordicus Partners Corporation, a biotech company specializing in developing breakthrough therapeutics for diseases with unmet medical needs in the United States. It develops medicines supporting oral health. The company was formerly known as EKIMAS Corporation and changed its name to Nordicus Partners Corporation in May 2023. Nordicus Partners Corporation was founded in 1993 and is based in Beverly Hills, California.

Valuation

ValueGrowthProfitHealthIncome29QUALITY
Overall Rating
40
Low quality
Low quality

Derived from filed metrics · High confidence (75% of the inputs available)

Moat Score10
Fair value estimate
$3.44-14.0% downside

Moat, fair value and rating computed by our valuation engine (ported from the original Python model).

Fundamentals

Market Cap
$42.50M
P/E Ratio
N/A
Dividend Yield
0.00%
Revenue Growth
0.0%
Profit Margin
0.0%
ROE
-6.5%
Debt / Equity
0.00
Beta
-0.74
Beaten Down

Statistics

Similar Stocks · Industrials

Latest News · NORD